Global Favipiravir Market Growth 2022-2028
As the global economy mends, the 2021 growth of Favipiravir will have significant change from previous year. According to our latest study, the global Favipiravir market size is USD million in 2022 from USD 335.3 million in 2021, with a change of % between 2021 and 2022. The global Favipiravir market size will reach USD 55 million in 2028, growing at a CAGR of -22.8% over the analysis period.
The United States Favipiravir market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Favipiravir market, reaching US$ million by the year 2028. As for the Europe Favipiravir landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Favipiravir players cover ChemRar Group, Glenmark, Fujifilm, and Dr. Reddy, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Favipiravir market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Brand Drug
Generic Drug
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Influenza Viruses
COVID-19
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
ChemRar Group
Glenmark
Fujifilm
Dr. Reddy
R-Pharma
Cipla
Lupin
Sun Pharma
Hisun Pharm
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Favipiravir Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Favipiravir by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Favipiravir by Country/Region, 2017, 2022 & 2028
2.2 Favipiravir Segment by Type
2.2.1 Brand Drug
2.2.2 Generic Drug
2.3 Favipiravir Sales by Type
2.3.1 Global Favipiravir Sales Market Share by Type (2017-2022)
2.3.2 Global Favipiravir Revenue and Market Share by Type (2017-2022)
2.3.3 Global Favipiravir Sale Price by Type (2017-2022)
2.4 Favipiravir Segment by Application
2.4.1 Influenza Viruses
2.4.2 COVID-19
2.4.3 Others
2.5 Favipiravir Sales by Application
2.5.1 Global Favipiravir Sale Market Share by Application (2017-2022)
2.5.2 Global Favipiravir Revenue and Market Share by Application (2017-2022)
2.5.3 Global Favipiravir Sale Price by Application (2017-2022)
3 Global Favipiravir by Company
3.1 Global Favipiravir Breakdown Data by Company
3.1.1 Global Favipiravir Annual Sales by Company (2020-2022)
3.1.2 Global Favipiravir Sales Market Share by Company (2020-2022)
3.2 Global Favipiravir Annual Revenue by Company (2020-2022)
3.2.1 Global Favipiravir Revenue by Company (2020-2022)
3.2.2 Global Favipiravir Revenue Market Share by Company (2020-2022)
3.3 Global Favipiravir Sale Price by Company
3.4 Key Manufacturers Favipiravir Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Favipiravir Product Location Distribution
3.4.2 Players Favipiravir Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Favipiravir by Geographic Region
4.1 World Historic Favipiravir Market Size by Geographic Region (2017-2022)
4.1.1 Global Favipiravir Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Favipiravir Annual Revenue by Geographic Region
4.2 World Historic Favipiravir Market Size by Country/Region (2017-2022)
4.2.1 Global Favipiravir Annual Sales by Country/Region (2017-2022)
4.2.2 Global Favipiravir Annual Revenue by Country/Region
4.3 Americas Favipiravir Sales Growth
4.4 APAC Favipiravir Sales Growth
4.5 Europe Favipiravir Sales Growth
4.6 Middle East & Africa Favipiravir Sales Growth
5 Americas
5.1 Americas Favipiravir Sales by Country
5.1.1 Americas Favipiravir Sales by Country (2017-2022)
5.1.2 Americas Favipiravir Revenue by Country (2017-2022)
5.2 Americas Favipiravir Sales by Type
5.3 Americas Favipiravir Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Favipiravir Sales by Region
6.1.1 APAC Favipiravir Sales by Region (2017-2022)
6.1.2 APAC Favipiravir Revenue by Region (2017-2022)
6.2 APAC Favipiravir Sales by Type
6.3 APAC Favipiravir Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Favipiravir by Country
7.1.1 Europe Favipiravir Sales by Country (2017-2022)
7.1.2 Europe Favipiravir Revenue by Country (2017-2022)
7.2 Europe Favipiravir Sales by Type
7.3 Europe Favipiravir Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Favipiravir by Country
8.1.1 Middle East & Africa Favipiravir Sales by Country (2017-2022)
8.1.2 Middle East & Africa Favipiravir Revenue by Country (2017-2022)
8.2 Middle East & Africa Favipiravir Sales by Type
8.3 Middle East & Africa Favipiravir Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Favipiravir
10.3 Manufacturing Process Analysis of Favipiravir
10.4 Industry Chain Structure of Favipiravir
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Favipiravir Distributors
11.3 Favipiravir Customer
12 World Forecast Review for Favipiravir by Geographic Region
12.1 Global Favipiravir Market Size Forecast by Region
12.1.1 Global Favipiravir Forecast by Region (2023-2028)
12.1.2 Global Favipiravir Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Favipiravir Forecast by Type
12.7 Global Favipiravir Forecast by Application
13 Key Players Analysis
13.1 ChemRar Group
13.1.1 ChemRar Group Company Information
13.1.2 ChemRar Group Favipiravir Product Offered
13.1.3 ChemRar Group Favipiravir Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 ChemRar Group Main Business Overview
13.1.5 ChemRar Group Latest Developments
13.2 Glenmark
13.2.1 Glenmark Company Information
13.2.2 Glenmark Favipiravir Product Offered
13.2.3 Glenmark Favipiravir Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Glenmark Main Business Overview
13.2.5 Glenmark Latest Developments
13.3 Fujifilm
13.3.1 Fujifilm Company Information
13.3.2 Fujifilm Favipiravir Product Offered
13.3.3 Fujifilm Favipiravir Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Fujifilm Main Business Overview
13.3.5 Fujifilm Latest Developments
13.4 Dr. Reddy
13.4.1 Dr. Reddy Company Information
13.4.2 Dr. Reddy Favipiravir Product Offered
13.4.3 Dr. Reddy Favipiravir Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Dr. Reddy Main Business Overview
13.4.5 Dr. Reddy Latest Developments
13.5 R-Pharma
13.5.1 R-Pharma Company Information
13.5.2 R-Pharma Favipiravir Product Offered
13.5.3 R-Pharma Favipiravir Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 R-Pharma Main Business Overview
13.5.5 R-Pharma Latest Developments
13.6 Cipla
13.6.1 Cipla Company Information
13.6.2 Cipla Favipiravir Product Offered
13.6.3 Cipla Favipiravir Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Cipla Main Business Overview
13.6.5 Cipla Latest Developments
13.7 Lupin
13.7.1 Lupin Company Information
13.7.2 Lupin Favipiravir Product Offered
13.7.3 Lupin Favipiravir Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Lupin Main Business Overview
13.7.5 Lupin Latest Developments
13.8 Sun Pharma
13.8.1 Sun Pharma Company Information
13.8.2 Sun Pharma Favipiravir Product Offered
13.8.3 Sun Pharma Favipiravir Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Sun Pharma Main Business Overview
13.8.5 Sun Pharma Latest Developments
13.9 Hisun Pharm
13.9.1 Hisun Pharm Company Information
13.9.2 Hisun Pharm Favipiravir Product Offered
13.9.3 Hisun Pharm Favipiravir Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Hisun Pharm Main Business Overview
13.9.5 Hisun Pharm Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Favipiravir Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Favipiravir Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Brand Drug
Table 4. Major Players of Generic Drug
Table 5. Global Favipiravir Sales by Type (2017-2022) & (K Units)
Table 6. Global Favipiravir Sales Market Share by Type (2017-2022)
Table 7. Global Favipiravir Revenue by Type (2017-2022) & ($ million)
Table 8. Global Favipiravir Revenue Market Share by Type (2017-2022)
Table 9. Global Favipiravir Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Favipiravir Sales by Application (2017-2022) & (K Units)
Table 11. Global Favipiravir Sales Market Share by Application (2017-2022)
Table 12. Global Favipiravir Revenue by Application (2017-2022)
Table 13. Global Favipiravir Revenue Market Share by Application (2017-2022)
Table 14. Global Favipiravir Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Favipiravir Sales by Company (2020-2022) & (K Units)
Table 16. Global Favipiravir Sales Market Share by Company (2020-2022)
Table 17. Global Favipiravir Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Favipiravir Revenue Market Share by Company (2020-2022)
Table 19. Global Favipiravir Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Favipiravir Producing Area Distribution and Sales Area
Table 21. Players Favipiravir Products Offered
Table 22. Favipiravir Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Favipiravir Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Favipiravir Sales Market Share Geographic Region (2017-2022)
Table 27. Global Favipiravir Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Favipiravir Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Favipiravir Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Favipiravir Sales Market Share by Country/Region (2017-2022)
Table 31. Global Favipiravir Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Favipiravir Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Favipiravir Sales by Country (2017-2022) & (K Units)
Table 34. Americas Favipiravir Sales Market Share by Country (2017-2022)
Table 35. Americas Favipiravir Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Favipiravir Revenue Market Share by Country (2017-2022)
Table 37. Americas Favipiravir Sales by Type (2017-2022) & (K Units)
Table 38. Americas Favipiravir Sales Market Share by Type (2017-2022)
Table 39. Americas Favipiravir Sales by Application (2017-2022) & (K Units)
Table 40. Americas Favipiravir Sales Market Share by Application (2017-2022)
Table 41. APAC Favipiravir Sales by Region (2017-2022) & (K Units)
Table 42. APAC Favipiravir Sales Market Share by Region (2017-2022)
Table 43. APAC Favipiravir Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Favipiravir Revenue Market Share by Region (2017-2022)
Table 45. APAC Favipiravir Sales by Type (2017-2022) & (K Units)
Table 46. APAC Favipiravir Sales Market Share by Type (2017-2022)
Table 47. APAC Favipiravir Sales by Application (2017-2022) & (K Units)
Table 48. APAC Favipiravir Sales Market Share by Application (2017-2022)
Table 49. Europe Favipiravir Sales by Country (2017-2022) & (K Units)
Table 50. Europe Favipiravir Sales Market Share by Country (2017-2022)
Table 51. Europe Favipiravir Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Favipiravir Revenue Market Share by Country (2017-2022)
Table 53. Europe Favipiravir Sales by Type (2017-2022) & (K Units)
Table 54. Europe Favipiravir Sales Market Share by Type (2017-2022)
Table 55. Europe Favipiravir Sales by Application (2017-2022) & (K Units)
Table 56. Europe Favipiravir Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Favipiravir Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Favipiravir Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Favipiravir Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Favipiravir Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Favipiravir Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Favipiravir Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Favipiravir Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Favipiravir Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Favipiravir
Table 66. Key Market Challenges & Risks of Favipiravir
Table 67. Key Industry Trends of Favipiravir
Table 68. Favipiravir Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Favipiravir Distributors List
Table 71. Favipiravir Customer List
Table 72. Global Favipiravir Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Favipiravir Sales Market Forecast by Region
Table 74. Global Favipiravir Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Favipiravir Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Favipiravir Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Favipiravir Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Favipiravir Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Favipiravir Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Favipiravir Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Favipiravir Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Favipiravir Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Favipiravir Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Favipiravir Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Favipiravir Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Favipiravir Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Favipiravir Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Favipiravir Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Favipiravir Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Favipiravir Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Favipiravir Revenue Market Share Forecast by Application (2023-2028)
Table 92. ChemRar Group Basic Information, Favipiravir Manufacturing Base, Sales Area and Its Competitors
Table 93. ChemRar Group Favipiravir Product Offered
Table 94. ChemRar Group Favipiravir Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. ChemRar Group Main Business
Table 96. ChemRar Group Latest Developments
Table 97. Glenmark Basic Information, Favipiravir Manufacturing Base, Sales Area and Its Competitors
Table 98. Glenmark Favipiravir Product Offered
Table 99. Glenmark Favipiravir Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. Glenmark Main Business
Table 101. Glenmark Latest Developments
Table 102. Fujifilm Basic Information, Favipiravir Manufacturing Base, Sales Area and Its Competitors
Table 103. Fujifilm Favipiravir Product Offered
Table 104. Fujifilm Favipiravir Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. Fujifilm Main Business
Table 106. Fujifilm Latest Developments
Table 107. Dr. Reddy Basic Information, Favipiravir Manufacturing Base, Sales Area and Its Competitors
Table 108. Dr. Reddy Favipiravir Product Offered
Table 109. Dr. Reddy Favipiravir Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. Dr. Reddy Main Business
Table 111. Dr. Reddy Latest Developments
Table 112. R-Pharma Basic Information, Favipiravir Manufacturing Base, Sales Area and Its Competitors
Table 113. R-Pharma Favipiravir Product Offered
Table 114. R-Pharma Favipiravir Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. R-Pharma Main Business
Table 116. R-Pharma Latest Developments
Table 117. Cipla Basic Information, Favipiravir Manufacturing Base, Sales Area and Its Competitors
Table 118. Cipla Favipiravir Product Offered
Table 119. Cipla Favipiravir Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 120. Cipla Main Business
Table 121. Cipla Latest Developments
Table 122. Lupin Basic Information, Favipiravir Manufacturing Base, Sales Area and Its Competitors
Table 123. Lupin Favipiravir Product Offered
Table 124. Lupin Favipiravir Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 125. Lupin Main Business
Table 126. Lupin Latest Developments
Table 127. Sun Pharma Basic Information, Favipiravir Manufacturing Base, Sales Area and Its Competitors
Table 128. Sun Pharma Favipiravir Product Offered
Table 129. Sun Pharma Favipiravir Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 130. Sun Pharma Main Business
Table 131. Sun Pharma Latest Developments
Table 132. Hisun Pharm Basic Information, Favipiravir Manufacturing Base, Sales Area and Its Competitors
Table 133. Hisun Pharm Favipiravir Product Offered
Table 134. Hisun Pharm Favipiravir Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 135. Hisun Pharm Main Business
Table 136. Hisun Pharm Latest Developments
List of Figures
Figure 1. Picture of Favipiravir
Figure 2. Favipiravir Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Favipiravir Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Favipiravir Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Favipiravir Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Brand Drug
Figure 10. Product Picture of Generic Drug
Figure 11. Global Favipiravir Sales Market Share by Type in 2021
Figure 12. Global Favipiravir Revenue Market Share by Type (2017-2022)
Figure 13. Favipiravir Consumed in Influenza Viruses
Figure 14. Global Favipiravir Market: Influenza Viruses (2017-2022) & (K Units)
Figure 15. Favipiravir Consumed in COVID-19
Figure 16. Global Favipiravir Market: COVID-19 (2017-2022) & (K Units)
Figure 17. Favipiravir Consumed in Others
Figure 18. Global Favipiravir Market: Others (2017-2022) & (K Units)
Figure 19. Global Favipiravir Sales Market Share by Application (2017-2022)
Figure 20. Global Favipiravir Revenue Market Share by Application in 2021
Figure 21. Favipiravir Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Favipiravir Revenue Market Share by Company in 2021
Figure 23. Global Favipiravir Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Favipiravir Revenue Market Share by Geographic Region in 2021
Figure 25. Global Favipiravir Sales Market Share by Region (2017-2022)
Figure 26. Global Favipiravir Revenue Market Share by Country/Region in 2021
Figure 27. Americas Favipiravir Sales 2017-2022 (K Units)
Figure 28. Americas Favipiravir Revenue 2017-2022 ($ Millions)
Figure 29. APAC Favipiravir Sales 2017-2022 (K Units)
Figure 30. APAC Favipiravir Revenue 2017-2022 ($ Millions)
Figure 31. Europe Favipiravir Sales 2017-2022 (K Units)
Figure 32. Europe Favipiravir Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Favipiravir Sales 2017-2022 (K Units)
Figure 34. Middle East & Africa Favipiravir Revenue 2017-2022 ($ Millions)
Figure 35. Americas Favipiravir Sales Market Share by Country in 2021
Figure 36. Americas Favipiravir Revenue Market Share by Country in 2021
Figure 37. United States Favipiravir Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Favipiravir Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Favipiravir Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Favipiravir Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Favipiravir Sales Market Share by Region in 2021
Figure 42. APAC Favipiravir Revenue Market Share by Regions in 2021
Figure 43. China Favipiravir Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Favipiravir Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Favipiravir Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Favipiravir Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Favipiravir Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Favipiravir Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Favipiravir Sales Market Share by Country in 2021
Figure 50. Europe Favipiravir Revenue Market Share by Country in 2021
Figure 51. Germany Favipiravir Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Favipiravir Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Favipiravir Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Favipiravir Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Favipiravir Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Favipiravir Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Favipiravir Revenue Market Share by Country in 2021
Figure 58. Egypt Favipiravir Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Favipiravir Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Favipiravir Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Favipiravir Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Favipiravir Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Favipiravir in 2021
Figure 64. Manufacturing Process Analysis of Favipiravir
Figure 65. Industry Chain Structure of Favipiravir
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
